International Cholangiocarcinoma
Research Network
The ICRN is a global collaboration of research groups from renowned institutions who are working in concert to improve knowledge about cholangiocarcinoma etiology, prevention, early detection, treatment, and prognosis. The network is comprised of highly talented individuals from a spectrum of disciplines, perspectives, and research methods who share a passion to make significant scientific advances to improve outcomes for patients with cholangiocarcinoma.
Our core
mission:
to rapidly translate scientific discoveries into practice for cholangiocarcinoma patients through a collaborative, highly translational international research network.
Our Executive Committee Leadership

Mitesh Borad, MD
Mayo Clinic

Nilo Azad, MD
John Hopkins University

Milind Javle, MD
MD Anderson Cancer Center

Stacie Lindsey
Cholangiocarcinoma Foundation

Reham Abdel-Wahab, MD, PhD
Cholangiocarcinoma Foundation
Our Executive Committee Members

Ghassan Abou-Alfa, MD
Memorial Sloan Kettering Cancer Center

Laura Goff, MD
Vanderbilt University

Lipika Goyal, MD
MGH/Harvard

Eugene Koay, MD, PhD
MD Anderson Cancer Center

Amit Mahipal, MBBS
Mayo Clinic

Shishir Maithel, MD
Winship Cancer Institute

Lewis Roberts, MB, ChB, PhD
Mayo Clinic

Flavio Rocha, MD
Oregon Health & Science University

Sameek Roychowdhury, MD, PhD
The Ohio State University

Rachna Shroff, MD
University of Arizona Cancer Center
International

John Bridgewater, PhD
University College London Hospital
United Kingdom

Suebpong Tanasanvimon, MD
Bumrungrad International Hospital, Thailand
Cholangiocarcinoma Foundation

Melinda Bachini
Cholangiocarcinoma Foundation
Director of Patient Services
The International Cholangiocarcinoma Research Network (ICRN) is a program of the Cholangiocarcinoma Foundation.